BNGO vs RARE · rev $14.9M vs rev $350.0M
Bionano Genomics Inc (BNGO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BNGO currently screens at market cap $13.4M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BNGO and RARE stock pages for the full models.
Not investment advice.